2020
DOI: 10.1007/s10815-020-01718-5
|View full text |Cite
|
Sign up to set email alerts
|

Live births following preimplantation genetic testing for dynamic mutation diseases by karyomapping: a report of three cases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 28 publications
0
7
0
Order By: Relevance
“…Embryologists selected blastocysts of grade 3 BC and above, and 3–5 trophectoderm (TE) cells were biopsied by laser irradiation. According to the standard protocol provided by the QIAGEN REPLI-g Single Cell kit, whole-genome amplification of TE cells obtained by biopsy was conducted, and the specific steps were as described previously [ 26 ]. The biopsied blastocysts were vitrified and preserved in liquid nitrogen.…”
Section: Methodsmentioning
confidence: 99%
“…Embryologists selected blastocysts of grade 3 BC and above, and 3–5 trophectoderm (TE) cells were biopsied by laser irradiation. According to the standard protocol provided by the QIAGEN REPLI-g Single Cell kit, whole-genome amplification of TE cells obtained by biopsy was conducted, and the specific steps were as described previously [ 26 ]. The biopsied blastocysts were vitrified and preserved in liquid nitrogen.…”
Section: Methodsmentioning
confidence: 99%
“…Additionally, 3-5 trophoblast cells were biopsied by the laser method. Whole genome amplification of the trophoblast cells was performed by multiple displacement amplification according to the standard protocol provided by the QIAGEN REPLI-g Single Cell kit, for which the specific steps were described in our previous study (22). The biopsied blastocysts were vitrified and preserved in liquid nitrogen.…”
Section: Ovarian Stimulation and Laboratory Protocolsmentioning
confidence: 99%
“…Almost three decades ago, the goal in the field was to provide accurate SCA2 presymptomatic diagnostic, prenatal diagnosis, and symptomatic treatment [ 72 ]. At present, preimplantation genetic testing by karyomapping enabled the first birth of three healthy babies without pathogenic CAG expansions for HD, SCA2 or SCA12 [ 73 ]. Currently, drug screening, experimental disease modelling, and deep-phenotyping studies in patients with SCA2 prepare the ground for future trials.…”
Section: Discussionmentioning
confidence: 99%